Iran Parliament Media Office Denies Reports of Speaker's Resignation from Negotiating Team
The media office of Iran's Parliament has denied reports that the parliament speaker resigned as head of the negotiating team. No new round of talks has been scheduled yet. This comes amid ongoing discussions related to negotiations, though specific details remain unclear.
apnews.comThe media office of Iran's Parliament issued a denial regarding reports that the parliament speaker had resigned from their position as head of the negotiating team. According to the statement, such reports are inaccurate, and the speaker has not stepped down from that role.
The media office also stated that no new round of talks has been scheduled at this time. This denial addresses circulating reports, though the office did not provide further details on the negotiating team's activities or future plans.
The situation remains ongoing, with potential for updates as more information becomes available.
Key Facts
Story Timeline
2 events- 2026-04-24
Iran Parliament Media office denied reports of the parliament speaker's resignation from the negotiating team.
1 source@financialjuice - Recent
Reports emerged claiming the parliament speaker resigned as head of the negotiating team.
1 source@financialjuice
Potential Impact
- 01
Diplomatic negotiations may continue without interruption if the denial holds.
- 02
Regional stakeholders could adjust expectations for upcoming talks.
- 03
Media coverage might prompt further clarifications from involved parties.
Transparency Panel
Related Stories
rte.ieOil Prices Fall More Than 12% on Reports of US-Iran Deal
Reports indicate the United States and Iran are close to a 14-point memorandum of understanding to conclude the ongoing conflict. Oil prices fell sharply after the news emerged before partially recovering following an Iranian announcement. President Donald J. Trump stated that co…
Restaurant Brands International Reports Q1 2026 Earnings
Restaurant Brands International posted first-quarter adjusted earnings per share of 86 cents and revenue of $2.26 billion. Both figures exceeded Wall Street forecasts. Net income attributable to common shareholders reached $338 million.
White House Projects $529 Billion in Potential Savings Over Decade From Trump-Era Drug Pricing Policy
White House economists projected $529 billion in savings over the next decade from agreements President Donald Trump reached with pharmaceutical companies. The analysis also forecasts $64.3 billion in Medicaid savings and up to $733 billion if the framework expands.